RubrYc Therapeutics announces Series A2 Preferred equity financing, collaboration, and RTX-003 license with iBio, Inc.

Must Read

RubrYc Therapeutics, Inc. (“RubrYc”) and iBio, Inc. (“iBio”, NYSEA: IBIO) announced today the closing of RubrYc’s Series A2 Preferred Financing, and concomitant License and Collaboration Agreements directed towards the …

Latest News

Ministry strengthens efforts to combat Hajj and Umrah scams

Jakarta (ANTARA) - Indonesian Ministry of Hajj and Umrah is revitalizing the role of Civil Servant Investigators (PPNS) to...

More Articles Like This